WildingJPHBatterhamRLDaviesMVan GaalLFKandlerKKonakliKet al
Summary: An FDA-approved oral option now expands choices beyond injectables or compounded semaglutide
November 17, 2025 - Annual D-SNP Model of Care Training - Required If you are a provider who has at least one Jefferson Health Plans Medicare Advantage Special (D-SNP) member assigned to your practice, at least one person on your staff who is involved in the care of our dual-eligible special needs plan (D-SNP) members must complete our annual D-SNP model of care training module
If you qualify, an OpenLoop Health provider will meet with you, review your eligibility and prescribe the right medication
Fibrosis Improvement : Emerging evidence suggests that GLP-1 medications may help slow or even reverse the progression of liver fibrosis, a condition in which excessive scar tissue forms in the liver
Given these findings, a phase II trial compared the effect of 5, 10, and 15 mg tirzepatide, 1.5 mg dulaglutide, and the placebo on the biomarkers of NASH and fibrosis in patients with T2DM [18]